Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
64.80    -0.10 (-0.15%)
Bid:
64.40
Ask:
65.20
Spread: 0.80 (1.242%)
Market Cap: £111.39m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Strategic Review Update

4 Mar 2024 11:15

RNS Number : 4666F
GCP Asset Backed Income Fund Ltd
04 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

FOR IMMEDIATE RELEASE

4 March 2024

GCP Asset Backed Income Fund Limited

("GABI" or the "Company")

LEI: 213800FBBZCQMP73A815

Strategic Review Update

On 29 January 2024, the Company announced that the board of GABI (the "Board") would be seeking shareholder feedback to inform its decision-making process in connection with the strategic review to consider how it may best deliver value to shareholders (the "Strategic Review").

The Board has today completed the shareholder consultation period in connection with the Strategic Review. Feedback has been provided to the Board by shareholders representing a majority of total voting rights in the Company. Views were canvassed on the future strategic direction of the Company, including in relation to: (i) a potential continuation of the Company in accordance with its current investment policy delivered by the Investment Manager, Gravis Capital Management Ltd; (ii) a suitable time horizon for the return of capital in a potential orderly wind-down of the Company; and (iii) acceptable pricing on a potential sale of the Company.

Shareholders have expressed a broad range of views throughout the consultation period. The Board is in the process of collating and reviewing the shareholder feedback and will announce the outcome of the Strategic Review in the week commencing 11 March 2024. The Board also expects to announce an update in relation to succession planning in respect of Board composition at that time.

The Board continues to consider a sale of the entire issued share capital of the Company as an option for the Company's future.

Alex Ohlsson, Chairman of GABI, commented:

"The Board is grateful to shareholders for their engagement in providing feedback in connection with the strategic review. This feedback will inform the Board's decision-making process for the future of the Company."

For further information:

GCP Asset Backed Income Fund Limited | +44 (0)15 3482 2251

Alex Ohlsson, Chairman

Barclays Bank PLC, acting through its Investment Bank (Financial Adviser and Corporate Broker) | +44 (0)20 7623 2323

Adrian Beidas

Callum West

Dion Di Miceli (Corporate Broking)

Stuart Muress (Corporate Broking)

About GABI

GABI is a closed-ended investment company traded on the Main Market of the LSE. The company makes investments secured against physical assets or contracted cash flows, in sectors which are integral to society.

Important notices

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction, whether pursuant to this announcement or otherwise.

The release, distribution or publication of this announcement in jurisdictions outside the United Kingdom may be restricted by laws of the relevant jurisdictions and therefore persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

Disclaimer

Barclays Bank PLC, acting through its Investment Bank ("Barclays"), which is authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority, is acting exclusively for the Company and no one else in connection with the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Barclays nor for providing advice in relation to any matter referred to in this announcement.

In accordance with the Code, normal United Kingdom market practice and Rule 14e-5(b) of the Exchange Act, Barclays and its affiliates will continue to act as exempt principal trader in the Company's securities on the London Stock Exchange. These purchases and activities by exempt principal traders which are required to be made public in the United Kingdom pursuant to the Code will be reported to a Regulatory Information Service and will be available on the London Stock Exchange website at www.londonstockexchange.com. This information will also be publicly disclosed in the United States to the extent that such information is made public in the United Kingdom.

Rule 26.1 disclosure

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available (subject to certain restrictions relating to persons resident in restricted jurisdictions) at https://www.graviscapital.com/funds/gabi-strategic-review/literature by no later than 12 noon (London time) on the business day following the date of this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSSLFFLELSEFD
Date   Source Headline
12th Jun 20264:22 pmRNSHolding(s) in Company
12th Jun 202612:32 pmRNSHolding(s) in Company
2nd Jun 20267:37 amRNSDisposal of care home loan portfolio
22nd May 202612:00 pmRNSResults of Annual General Meeting
29th Apr 20265:45 pmRNSDividend Declaration
15th Apr 20269:30 amRNSNotice of Annual General Meeting
31st Mar 20267:00 amRNSAnnual Report and Accounts
19th Feb 20267:00 amRNSInvestor report at 31 December 2025
2nd Feb 20267:00 amRNSRealisation Plan Update, NAV and Dividend
31st Dec 20257:00 amRNSTotal Voting Rights
10th Dec 20252:27 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSThird Capital Distribution Update
26th Nov 20257:00 amRNSThird Compulsory Redemption & Dividend Declaration
11th Sep 20257:00 amRNSHalf-year Report
13th Aug 20257:00 amRNSInvestor report at 30 June 2025
24th Jul 20257:00 amRNSNet Asset Value and Dividend Declaration
20th Jun 20254:01 pmRNSHolding(s) in Company
6th Jun 202510:53 amRNSResults of Annual General Meeting
27th May 20252:05 pmRNSHolding(s) in Company
15th May 20254:30 pmRNSHolding(s) in Company
15th May 20254:28 pmRNSHolding(s) in Company
8th May 20259:30 amRNSNotice of Annual General Meeting
6th May 20251:10 pmRNSChange of Auditor
1st May 202510:21 amRNSDividend Declaration
30th Apr 20257:00 amRNSAnnual Report and Accounts
27th Feb 20257:00 amRNSInvestor report at 31 December 2024
12th Feb 20257:00 amRNSNet Asset Value and Dividend Declaration
4th Dec 20246:23 pmRNSHolding(s) in Company
29th Nov 20247:00 amRNSTotal Voting Rights
19th Nov 20241:33 pmRNSHolding(s) in Company
18th Nov 20247:00 amRNSSecond Capital Distribution Update
6th Nov 20246:20 pmRNSDividend & Second Compulsory Redemption
6th Nov 20247:00 amRNSDividend & Second Compulsory Redemption
18th Oct 20247:00 amRNSSecond Compulsory Redemption
19th Sep 20247:00 amRNSHalf-Yearly Report & Financial Statements
27th Aug 20247:00 amRNSInvestor report at 30 June 2024
30th Jul 20247:00 amRNSDividend Declaration
26th Jul 20247:00 amRNSQuarterly Update
23rd Jul 202410:56 amRNSDirector Declaration
8th Jul 20244:03 pmRNSLoan Repayment
4th Jul 20244:10 pmRNSPublication of Managed Realisation Plan
1st Jul 202412:23 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSTotal Voting Rights
11th Jun 20247:00 amRNSInitial Capital Distribution Update
7th Jun 20244:04 pmRNSCancellation of Shares held in Treasury
3rd Jun 20242:42 pmRNSLoan Repayment & Increased Return of Capital
30th May 20245:39 pmRNSDirector/PDMR Shareholding
29th May 20244:47 pmRNSForm 8.3 - GCP Asset Backed Income Fund Limited
29th May 20243:29 pmRNSForm 8.3 - GCP Asset Backed Income Fund Ltd
29th May 20242:01 pmRNSReturn of Capital & Conclusion of Strategic Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.